Jezová-Repceková D, Klimes I, Jurcovicová J, Vigas M
Int J Clin Pharmacol Biopharm. 1979 Feb;17(2):64-7.
The effect of several drugs presumably influencing central catecholaminergic receptors on plasma cortisol and GH response to insulin-induced hypoglycemia was studied in healthy adult males. The intravenous infusion of alpha-adrenergic blocking agents tolazoline or phentolamine supressed plasma cortisol and GH response to insulin-induced hypoglycemia. After an infusion of beta-adrenergic antagonist propranolol both hypoglycemia and rise in plasma cortisol and GH were prolonged. Finally, the administration of dopaminergic blocker pimozide failed to affect the plasma cortisol response, but slightly suppressed the enhancement of GH release during hypoglycemia. Caution is recommended before making suggestions about neuroendocrine regulations from the data obtained after systemic administration of drugs. Nevertheless, it may be concluded that the hypothesis on the inhibitory role of the central alpha-adrenergic system on ACTH secretion suggested in rats and dogs was not confirmed by our results obtained in man.
在健康成年男性中研究了几种可能影响中枢儿茶酚胺能受体的药物对血浆皮质醇和生长激素(GH)对胰岛素诱导低血糖反应的影响。静脉输注α-肾上腺素能阻滞剂妥拉唑啉或酚妥拉明可抑制血浆皮质醇和GH对胰岛素诱导低血糖的反应。输注β-肾上腺素能拮抗剂普萘洛尔后,低血糖以及血浆皮质醇和GH的升高均延长。最后,给予多巴胺能阻滞剂匹莫齐特未能影响血浆皮质醇反应,但略微抑制了低血糖期间GH释放的增强。在根据全身给药后获得的数据对神经内分泌调节提出建议之前,建议谨慎行事。然而,可以得出结论,在大鼠和狗中提出的关于中枢α-肾上腺素能系统对促肾上腺皮质激素(ACTH)分泌具有抑制作用的假说,未被我们在人类中获得的结果所证实。